Ambiq Micro (NYSE:AMBQ) Cut to “Sell” at Wall Street Zen

Wall Street Zen cut shares of Ambiq Micro (NYSE:AMBQ) from a hold rating to a sell rating in a research note issued to investors on Saturday.

Other research analysts have also recently issued reports about the company. UBS Group lowered their target price on Ambiq Micro from $40.00 to $32.00 and set a “neutral” rating for the company in a research note on Monday, October 27th. Weiss Ratings initiated coverage on Ambiq Micro in a research note on Thursday, October 23rd. They issued a “sell (e-)” rating for the company. Two investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $41.75.

Ambiq Micro Trading Up 0.6%

NYSE:AMBQ opened at $29.51 on Friday. Ambiq Micro has a 52 week low of $22.12 and a 52 week high of $51.76. The stock has a fifty day simple moving average of $30.93. The firm has a market capitalization of $540.24 million and a P/E ratio of -1.49.

Insider Activity

In other Ambiq Micro news, Director Joseph A. Tautges sold 7,800 shares of the firm’s stock in a transaction dated Monday, January 26th. The stock was sold at an average price of $31.00, for a total transaction of $241,800.00. Following the transaction, the director owned 48,746 shares of the company’s stock, valued at approximately $1,511,126. This trade represents a 13.79% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CTO Scott Mclean Hanson sold 10,000 shares of the business’s stock in a transaction dated Monday, January 26th. The shares were sold at an average price of $31.00, for a total value of $310,000.00. Following the completion of the sale, the chief technology officer directly owned 122,818 shares of the company’s stock, valued at $3,807,358. The trade was a 7.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing.

Institutional Investors Weigh In On Ambiq Micro

Several hedge funds have recently made changes to their positions in AMBQ. Barclays PLC raised its position in Ambiq Micro by 28.7% in the fourth quarter. Barclays PLC now owns 8,451 shares of the company’s stock worth $241,000 after acquiring an additional 1,883 shares in the last quarter. Alyeska Investment Group L.P. grew its stake in shares of Ambiq Micro by 75.5% during the 4th quarter. Alyeska Investment Group L.P. now owns 32,832 shares of the company’s stock worth $936,000 after purchasing an additional 14,122 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in shares of Ambiq Micro by 9.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 33,833 shares of the company’s stock valued at $964,000 after purchasing an additional 2,981 shares in the last quarter. State Street Corp increased its holdings in shares of Ambiq Micro by 16.9% in the 4th quarter. State Street Corp now owns 84,507 shares of the company’s stock valued at $2,408,000 after purchasing an additional 12,211 shares in the last quarter. Finally, Wells Fargo & Company MN lifted its stake in shares of Ambiq Micro by 71.5% in the fourth quarter. Wells Fargo & Company MN now owns 5,344 shares of the company’s stock valued at $152,000 after purchasing an additional 2,228 shares during the period.

Ambiq Micro Company Profile

Ambiq Micro (NYSE: AMBQ) is a semiconductor company specializing in the design and development of ultra-low-power microcontroller units (MCUs) and application-specific integrated circuits (ASICs). The company’s core technology leverages sub-threshold voltage operation to dramatically reduce energy consumption, enabling extended battery life in a broad range of portable and always-on devices. Ambiq’s products are particularly well suited for applications where power efficiency is critical, such as wearable electronics, IoT sensors, medical monitoring equipment, and industrial automation systems.

The company’s flagship product family, the Apollo series of MCUs, offers multi-core architectures, integrated wireless connectivity options, and advanced security features.